RecruitingNot applicableNCT06358469

STRatIfication of Vulvar SCC by HPV and p53 Status to Guide Excision

Studying Vulvar squamous cell carcinoma

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Canadian Cancer Trials Group
Principal Investigator: Amy Jamieson
University of British Columbia, Vancouver, BC, Canada
Intervention: Surgery(procedure)
Enrollment: 249 enrolled
Eligibility: 18 years · FEMALE
Timeline: 2024 – 2031

Study locations (10)

BCCA - Kelowna, Kelowna, British Columbia, Canada
BCCA - Vancouver, Vancouver, British Columbia, Canada
Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada
Odette Cancer Centre, Toronto, Ontario, Canada
University Health Network, Toronto, Ontario, Canada
CHUM-Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada
Hotel-Dieu de Quebec, Québec, Quebec, Canada
CIUSSS de l'Estrie - Centre hospitalier, Sherbrooke, Quebec, Canada
Allan Blair Cancer Centre, Regina, Saskatchewan, Canada
Auckland City Hospital, Auckland, New Zealand

Collaborators

Australia New Zealand Gynaecological Oncology Group

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06358469 on ClinicalTrials.gov

Other trials for Vulvar squamous cell carcinoma

Additional recruiting or active studies for the same condition.

See all trials for Vulvar squamous cell carcinoma →

← Back to all trials